Pharmacopeia
Midazolam
Core pharmacology
- Legacy Cicm Level
Level 1
- Chemical Pharmaceutics
- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam- Presentation
Clear solution pH 3.5 (IV/IM), Tablet
pKa 6.5 – 89% un-ionized- Mechanism of action
increases the sensitivity GABAA receptors which open (via GABA) and allow Cl influx
causing hyperpolarisation
- Influx of Cl- into nerve cell
- Hyperpolarised, preventing conduction- Physiological effects
CNS: Sedative, reduces epileptiform activity,
increases confusion and disorientation, amnesic properties more prominent than
sedative eff¬ects
CVS: minor hypotension has been reportedResp: respiratory depression - synergistic with opioids
- Absorption
A : IV,PO,In,IM
poor oral bioavailability 45%- Metabolism
hepatic via CYP3A4, and glucuronidation
active metabolite- Excretion
excreted in urine (as glucuronide conjugated metabolites)
- Half-life
half life 1-4 hrs
prolonged in cirrhosis, CRF, CCF, obesity, elderly- Route And Dose
2-2.5mg initially then 1mg boluses to eff¬ect
- Introduction
- Benzodiazepine
- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam- Indications Uses
Sedative, amnesic+ anxiolytic,
antiepileptic- Distribution
lipid soluble at physiological pH (pKa 6.5).
high lipid sol crosses BBB
Neurology & Sedation · Neurology & Sedation
- Class Group
Anticonvulsant
Sedative-Hypnotic- Adverse Effects Toxicity
Respiratory depression and excessive sedation with overdosage
Same CYP as alfentanil (increases effect)- Protein binding
highly protein bound (95%)
- Volume of distribution
small-mod Vd = 1-2 L/kg
high lipid sol crosses BBB- Class Group
Sedative / Hypnotic
- Adverse Effects Toxicity
Respiratory depression and excessive sedation with overdosage
Same CYP as alfentanil (increases e¬ffect)- Protein binding
95%
- Volume of distribution
1-2 L/kg